AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Mycomune-S 360 Tablet

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Mycophenolate sodium (360mg)

Overview Mycomune-S 360 Tablet

Immunosuppressant medication, Mycomune-S 360 Tablet, is administered post-transplant (kidney, heart, liver, etc.) to prevent organ rejection. Its mechanism involves immune system suppression, hindering the body's attack on the new organ. Dosage varies depending on the transplant type; strictly adhere to your physician's instructions. This medication can be taken with or without food; swallow whole – do not crush, chew, or break. Continuous use is crucial for optimal efficacy and rejection prevention. Discontinuation increases rejection risk. Treatment duration is determined by your need for rejection prophylaxis. Common side effects include gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), headache, hypertension, and altered white blood cell counts. Immunosuppression elevates infection susceptibility and cancer risk. A comprehensive list of potential side effects exists; discuss these with your doctor, noting that some require immediate medical attention. This medication is contraindicated during pregnancy, breastfeeding, or pregnancy planning due to risks of birth defects and miscarriage. Prior to commencing treatment, inform your doctor of any infections, unusual bleeding or bruising, past digestive issues, and all other medications you are currently taking, as interactions are possible. Regular blood tests will monitor blood cell counts. Report any unexplained bruising/bleeding, sore throat, mouth sores, or fever immediately.

Primary Ingredients of Mycomune-S 360 Tablet

No text was provided to rewrite.

Uses of Mycomune-S 360 Tablet

Avoiding transplant organ rejection

Major Benefits of Mycomune-S 360 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Mycomune-S 360 Tablet. Ingest the tablet whole; do not break, crush, or chew it. This medication can be administered with or without food, although consistent timing is recommended.

Common Side effects of Mycomune-S 360 Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Mycomune-S 360 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Mycomune-S 360 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.

How Mycomune-S 360 Tablet works:

Immunosuppression is achieved with Mycomune-S 360 Tablets, which lessen the body's natural immune response, thereby hindering organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

Mycomune-S 360 Tablet's concurrent use with alcohol presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mycomune-S 360 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it is not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Mycomune-S 360 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mycomune-S 360 Tablet.

KidneyKidneyCAUTION

Individuals with severe kidney impairment should exercise caution when using Mycomune-S 360 Tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Mycomune-S 360 Tablet in individuals with liver conditions is likely safe. Preliminary findings indicate dose modification may not be necessary, however, physician consultation is recommended.

What if you forget to take Mycomune-S 360 Tablet :

Should you forget to take a Mycomune-S 360 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mycomune-S 360 Tablet

LabelValue
Chemical Type Phthalide-based compound
Developing Habits No.
Treatment Category Cancer Medications
Actions Purine analog immunosuppressants

FAQs on Mycomune-S 360 Tablet

Mycomune-S 360 Tablet is an immunosuppressant prescribed to help your body accept the transplanted kidney. By suppressing your immune system's response to foreign substances, it reduces the risk of organ rejection.
Taking Mycomune-S 360 Tablet may increase your risk of developing certain cancers, including skin cancer and lymphoma. Minimize sun exposure when outdoors, wear protective clothing and sunscreen. Consult your doctor immediately if you notice any new skin sores or bumps, changes in moles, unusual brown or black skin lesions with irregular borders, asymmetrical sores, unexplained skin changes, non-healing sores, persistent fatigue, unintentional weight loss, or swollen/painful lymph nodes (neck, groin, armpits).
Mycomune-S 360 Tablet isn't a steroid or chemotherapy drug; it's an immunosuppressant. This means it weakens the immune system to prevent organ rejection. Hair loss is a frequent side effect.
Mycomune-S 360 Tablet may impact blood counts, kidneys, and liver function; therefore, a blood test is required before treatment begins. Regular blood tests throughout treatment will monitor your response and detect any side effects.
Mycomune-S 360 Tablet weakens your immune system. Because your immunity is already compromised, contact with chicken pox or shingles could cause you to develop these infections. Your doctor's caution is therefore vital. Contact them immediately if you develop either illness, as you may need specific treatment.
Avoid Mycomune-S 360 Tablet if pregnant or planning pregnancy. First-trimester use carries a high risk of miscarriage and birth defects. Therefore, use two reliable forms of contraception concurrently for four weeks prior to, throughout, and for six weeks after treatment. Your doctor will recommend suitable methods. Note that Mycomune-S 360 Tablet may reduce the efficacy of birth control pills, necessitating a second contraceptive method.
Reliable contraception should be used by either the man or his partner throughout treatment and for 90 days afterward. Men should refrain from donating semen during and for 90 days after Mycomune-S 360 Tablet treatment.
Mycomune-S 360 Tablet
1,213